Article
Linking pharmacovigilance with pharmacogenetics.
Drug safety - 1 Jan 2004
Clark David W J, Donnelly Emma, Coulter David M, Roberts Rebecca L, Kennedy Martin A
Abstract excerpt
The ability to identify individuals who are susceptible to adverse drug reactions (ADRs) has the potential to reduce the personal and population costs of drug-related morbidity. Some individuals may show an increased susceptibility to certain ADRs through genetic polymorphisms that alter their responses to various drugs. We wished to establish a methodology that would be acceptable to members of the general...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.